1. Home
  2. LQDT vs KALV Comparison

LQDT vs KALV Comparison

Compare LQDT & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liquidity Services Inc.

LQDT

Liquidity Services Inc.

HOLD

Current Price

$31.83

Market Cap

859.6M

ML Signal

HOLD

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$17.00

Market Cap

551.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LQDT
KALV
Founded
1999
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
859.6M
551.2M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
LQDT
KALV
Price
$31.83
$17.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
8
Target Price
$38.50
$26.43
AVG Volume (30 Days)
220.1K
1.6M
Earning Date
11-20-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
38.09
N/A
EPS
0.87
N/A
Revenue
$476,669,000.00
$1,426,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$204.16
P/E Ratio
$36.57
N/A
Revenue Growth
31.20
N/A
52 Week Low
$21.67
$7.30
52 Week High
$39.72
$17.28

Technical Indicators

Market Signals
Indicator
LQDT
KALV
Relative Strength Index (RSI) 76.10 70.46
Support Level $29.72 $15.88
Resistance Level $31.96 $17.10
Average True Range (ATR) 0.78 1.08
MACD 0.24 0.22
Stochastic Oscillator 97.71 96.52

Price Performance

Historical Comparison
LQDT
KALV

About LQDT Liquidity Services Inc.

Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Capital Assets Group (CAG), Retail Supply Chain Group (RSCG), and Machinio. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Share on Social Networks: